Chunjun Li
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Diabetes Treatment and Management
Papers in
-
- Metabolism, Diabetes, and Cancer 6
- Peroxisome Proliferator-Activated Receptors 5
- Physiology 14
- Co-authors
- De-min Yu (20 shared papers)Liming Chen (13 shared papers)Lin Lv (7 shared papers)Ming‐Lin Liu (6 shared papers)Bei Sun (13 shared papers)Qiu-Mei Zhang (10 shared papers)Pei Yu (10 shared papers)Hui Li (1 shared paper)
- Journals
- Diabetology & Metabolic Syndrome (6 papers)Diabetes Metabolic Syndrome and Obesity (4 papers)Cardiovascular Diabetology (3 papers)Frontiers in Pharmacology (3 papers)Frontiers in Endocrinology (3 papers)
- Partner nations
- ChinaUnited StatesSweden
In The Last Decade
Chunjun Li
109 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 132
- Cancer Research 355
- Endocrinology, Diabetes and Metabolism 339
- Nephrology 142
- Cardiology and Cardiovascular Medicine 276
- Complementary and alternative medicine 97
Countries citing papers authored by Chunjun Li
This map shows the geographic impact of Chunjun Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chunjun Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chunjun Li more than expected).
Fields of papers citing papers by Chunjun Li
This network shows the impact of papers produced by Chunjun Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chunjun Li. The network helps show where Chunjun Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Chunjun Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 111 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 157 | |
| 2 | 2008 | 153 | |
| 3 | 2014 | 128 | |
| 4 | 2017 | 112 | |
| 5 | 2013 | 108 | |
| 6 | 2020 | 97 | |
| 7 | 2020 | 84 | |
| 8 | 2014 | 75 | |
| 9 | 2016 | 73 | |
| 10 | 2016 | 66 | |
| 11 | 2021 | 59 | |
| 12 | 2015 | 58 | |
| 13 | 2012 | 58 | |
| 14 | Attenuation of myocardial apoptosis by alpha-lipoic acid through suppression of mitochondrial oxidative stress to reduce diabetic cardiomyopathy. | 2009 | 51 |
| 15 | 2017 | 46 | |
| 16 | 2019 | 46 | |
| 17 | 2014 | 43 | |
| 18 | 2014 | 40 | |
| 19 | 2016 | 37 | |
| 20 | 2020 | 34 |
About Chunjun Li
Chunjun Li is a scholar working on Molecular Biology, Physiology, Epidemiology, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine, having authored 111 papers that have together received 2.3k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (9 papers), Metabolism, Diabetes, and Cancer (6 papers), Peroxisome Proliferator-Activated Receptors (5 papers), Cancer-related molecular mechanisms research (5 papers), Liver Disease Diagnosis and Treatment (5 papers), Gout, Hyperuricemia, Uric Acid (5 papers), Adipokines, Inflammation, and Metabolic Diseases (5 papers) and Sleep and related disorders (5 papers). The work is most often cited by research in Cancer Research (355 citations), Endocrinology, Diabetes and Metabolism (339 citations), Nephrology (142 citations), Cardiology and Cardiovascular Medicine (276 citations) and Complementary and alternative medicine (97 citations). Chunjun Li has collaborated with scholars based in China, United States and Sweden. Frequent co-authors include De-min Yu, Liming Chen, Lin Lv, Ming‐Lin Liu, Bei Sun, Qiu-Mei Zhang, Pei Yu, Hui Li, Qianhua Fang and Jing‐Na Lin. Their work appears in journals such as Diabetology & Metabolic Syndrome, Diabetes Metabolic Syndrome and Obesity, Cardiovascular Diabetology, Frontiers in Pharmacology and Frontiers in Endocrinology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.